Showing results (11-20 of 159) with videos related to
Sort By:
Pageof 16
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 10, 2003
Cocaine abusers have an overexpression of alpha-synuclein in dopamine neuronsDeborah C Mash, Qinjie Ouyang, John Pablo, et al.Journal of Neuroimmunology|January 18, 2021
Leveraging molecular biomarkers to make the common diagnosis in the uncommon patientGregory S Day, Brian A Gordon, Robert C Bucelli, et al.Acta Neuropathologica Communications|August 29, 2020
Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brainKanta Horie, Nicolas R Barthélemy, Nipun Mallipeddi, et al.Acta Neuropathologica|November 26, 2025
Neuropathologic correlates of cognitive impairment in Alzheimer's disease with discordant CSF biomarker profiles: co-pathologies in focusKonstantinos Ioannou, Richard J Perrin, Khadidzha Abdullaieva, et al.Annals of Clinical and Translational Neurology|January 7, 2021
Flortaucipir (tau) PET in LGI1 antibody encephalitisGregory S Day, Brian A Gordon, Austin McCullough, et al.Parkinson'S Disease|July 30, 2019
Neuroinflammation and Myelin Status in Alzheimer's Disease, Parkinson's Disease, and Normal Aging Brains: A Small Sample StudyFei Han, Richard J Perrin, Qing Wang, et al.Annals of Clinical and Translational Neurology|August 13, 2019
Translocator protein in late stage Alzheimer's disease and Dementia with Lewy bodies brainsJinbin Xu, Jianjun Sun, Richard J Perrin, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 1, 2024
The Alzheimer's Disease Neuroimaging Initiative Neuropathology Core: An updateRichard J Perrin, Erin E Franklin, Haley Bernhardt, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 4, 2023
Identifying individuals with non-Alzheimer's disease co-pathologies: A precision medicine approach to clinical trials in sporadic Alzheimer's diseaseDuygu Tosun, Ozlem Yardibi, Tammie L S Benzinger, et al.Plos One|May 24, 2013
Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variationRichard J Perrin, Jacqueline E Payton, James P Malone, et al.Pageof 16